Articles | Open Access | https://doi.org/10.37547/ajbspi/Volume04Issue06-11

CHARACTERISTICS OF PATHOMORPHOLOGICAL CHANGES OF ALCOHOLIC CARDIOMYOPATHY

Oripova Ozoda Olimovna , Samarkand State Medical University, Samarkand, Uzbekistan

Abstract

Effects of alcohol metabolites, mainly acetaldehyde, on the heart. Disturbances in metabolism and electrolyte imbalance lead to arrhythmias and disturbances in the functional activity of the heart. Acetaldehyde disrupts the synthesis of several compounds and increases the synthesis of inflammatory cytokines and leads to the development of an autoimmune process. The weight of the heart is 500-550 gr. and it is observed that it is filled with fat. When the heart is placed on the operating table, it is diffuse, similar to infectious myocarditis, and the heart is red or purple in color.

Keywords

Alcohol, cardiomyocyte, heart

References

Carvalho M.V.H., Kroll P.C., Kroll R.T.M., Carvalho V.N. Cirrhotic cardiomyopathy: the liver affects the heart. // Braz. J. Med. Biol. Res. -2019. - Feb 14. - №52(2). Р.7809.

Elleuch N., Mrabet S., Ben Slama A., Jaziri H., Hammami A., Brahim A., Ajmi S., Ksiaa M., Jmaa A. Cirrhotic cardiomyopathy. // Tunis Med. – 2020. – Mar. - № 98(3). – Р.206-210.

Karafiatova L., Pika T. Amyloid cardiomyopathy. // Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. – 2017. – Jun. - № 161(2). – Р.117-127.

Yu J., Zeng C., Wang Y. Epigenetics in dilated cardiomyopathy. // Curr. Opin. Cardiol -. 2019. – May. - №34 (3). – Р.260-269.

Yuan S.M. Cardiomyopathy in the pediatric patients. // Pediatr Neonatol. -2018. – Apr. - №59 (2). – Р.120-128.

Zardi E.M., Abbate A, Zardi D.M., Dobrina A., Margiotta D., Van Tassell B.W., Afeltra A., Sanyal A.J. Cirrhotic cardiomyopathy. // J. Am. Coll. Cardiol.- 2010. - Aug 10. -№56 (7). – Р.539-49.

Article Statistics

Copyright License

Download Citations

How to Cite

Oripova Ozoda Olimovna. (2024). CHARACTERISTICS OF PATHOMORPHOLOGICAL CHANGES OF ALCOHOLIC CARDIOMYOPATHY. American Journal Of Biomedical Science & Pharmaceutical Innovation, 4(06), 79–86. https://doi.org/10.37547/ajbspi/Volume04Issue06-11